Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $216.47 | 11 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $55.40 | 3 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $54.64 | 2 | $0 (2024) |
| GENZYME CORPORATION | $24.91 | 1 | $0 (2020) |
| PFIZER INC. | $20.30 | 1 | $0 (2023) |
| Allergan Inc. | $18.59 | 1 | $0 (2019) |
| Janssen Biotech, Inc. | $15.91 | 1 | $0 (2024) |
| Galderma Laboratories, L.P. | $13.88 | 1 | $0 (2023) |
| ABBVIE INC. | $12.84 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $95.54 | 4 | Novartis Pharmaceuticals Corporation ($43.41) |
| 2023 | $52.60 | 3 | PFIZER INC. ($20.30) |
| 2022 | $12.84 | 1 | ABBVIE INC. ($12.84) |
| 2020 | $24.91 | 1 | GENZYME CORPORATION ($24.91) |
| 2019 | $18.59 | 1 | Allergan Inc. ($18.59) |
| 2017 | $11.99 | 1 | Novartis Pharmaceuticals Corporation ($11.99) |
All Payment Transactions
11 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/25/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $36.22 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 09/10/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $22.41 | General |
| Category: Dermatology | ||||||
| 08/29/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $15.91 | General |
| Category: Immunology | ||||||
| 08/15/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $21.00 | General |
| Category: Dermatology | ||||||
| 04/26/2023 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $13.88 | General |
| 04/19/2023 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $18.42 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 02/21/2023 | PFIZER INC. | EUCRISA (Drug), CIBINQO | Food and Beverage | In-kind items and services | $20.30 | General |
| Category: DERMATOLOGY | ||||||
| 12/21/2022 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $12.84 | General |
| Category: IMMUNOLOGY | ||||||
| 11/17/2020 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $24.91 | General |
| Category: Immunology | ||||||
| 01/31/2019 | Allergan Inc. | BOTOX COSMETIC (Biological) | Food and Beverage | In-kind items and services | $18.59 | General |
| 08/08/2017 | Novartis Pharmaceuticals Corporation | COSENTYX (Biological) | Food and Beverage | In-kind items and services | $11.99 | General |
| Category: DERMATOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 1,427 | 2,304 | $348,684 | $127,451 |
| 2022 | 12 | 1,307 | 1,952 | $287,205 | $108,382 |
| 2021 | 12 | 1,175 | 1,756 | $234,344 | $97,457 |
| 2020 | 12 | 1,243 | 1,828 | $243,762 | $91,317 |
All Medicare Procedures & Services
50 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 511 | 893 | $147,560 | $54,172 | 36.7% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 238 | 305 | $52,150 | $21,984 | 42.2% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 211 | 305 | $38,125 | $13,188 | 34.6% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 40 | 46 | $23,690 | $10,454 | 44.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 36 | 68 | $15,380 | $5,865 | 38.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 88 | 112 | $14,000 | $4,650 | 33.2% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 40 | 48 | $8,640 | $4,118 | 47.7% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 30 | 35 | $15,925 | $3,491 | 21.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 44 | 44 | $8,540 | $2,973 | 34.8% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 16 | 17 | $5,015 | $2,239 | 44.6% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 115 | 344 | $13,760 | $1,791 | 13.0% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 32 | 35 | $2,905 | $1,391 | 47.9% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 13 | 26 | $2,734 | $1,115 | 40.8% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 13 | 26 | $260.00 | $20.47 | 7.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 463 | 766 | $121,600 | $46,236 | 38.0% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 244 | 288 | $47,520 | $20,352 | 42.8% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 195 | 265 | $33,125 | $11,579 | 35.0% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2022 | 28 | 30 | $15,450 | $7,483 | 48.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 35 | 60 | $13,080 | $5,013 | 38.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 72 | 72 | $13,680 | $4,900 | 35.8% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 39 | 44 | $7,920 | $3,635 | 45.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 84 | 94 | $11,280 | $3,584 | 31.8% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2022 | 15 | 18 | $8,190 | $1,935 | 23.6% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2022 | 36 | 39 | $3,120 | $1,588 | 50.9% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 81 | 261 | $10,440 | $1,350 | 12.9% |
About Dr. David Uptmore, MD
Dr. David Uptmore, MD is a Dermatology healthcare provider based in Katy, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/30/2007. The National Provider Identifier (NPI) number assigned to this provider is 1649317819.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Uptmore, MD has received a total of $216.47 in payments from pharmaceutical and medical device companies, with $95.54 received in 2024. These payments were reported across 11 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($216.47).
As a Medicare-enrolled provider, Uptmore has provided services to 5,152 Medicare beneficiaries, totaling 7,840 services with total Medicare billing of $424,607. Data is available for 4 years (2020–2023), covering 50 distinct procedure/service records.
Practice Information
- Specialty Dermatology
- Location Katy, TX
- Active Since 01/30/2007
- Last Updated 09/20/2010
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1649317819
Products in Payments
- DUPIXENT (Biological) $79.55
- COSENTYX (Drug) $43.41
- EUCRISA (Drug) $20.30
- BOTOX COSMETIC (Biological) $18.59
- TREMFYA (Drug) $15.91
- RINVOQ (Biological) $12.84
- COSENTYX (Biological) $11.99
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Katy
Connie Wang, M.d, M.D
Dermatology — Payments: $55,293
Filiberto Cedeno Laurent, Md, Phd, MD, PHD
Dermatology — Payments: $23,083
Danielle Applebaum
Dermatology — Payments: $16,965
Uyen Ngoc Mui, Md, MD
Dermatology — Payments: $10,381
Rachel Schmidtberger, M.d, M.D
Dermatology — Payments: $9,055
Dr. Sana Zahiruddin, M.d, M.D
Dermatology — Payments: $8,857